Skip to Main Content

Chapter 67: Mature T-Cell and Natural Killer Cell Lymphomas

INTRODUCTION

  • The term peripheral T-cell lymphoma (PTCL) refers to lymphomas originating in a mature (ie, post-thymic) T cell.

  • PTCLs make up 10% to 15% of all non-Hodgkin lymphomas and represent 28 heterogeneous diseases as currently classified.

  • Table 67–1 lists the mature T-cell and natural killer (NK) cell lymphomas excluding primary cutaneous lymphoma.

  • The four most common entities make up 60% to 65% of cases in the United States and northern Europe; these are PTCL not otherwise specified (PTCL-NOS), angioimmunoblastic T-cell lymphoma (AITL), anaplastic lymphoma kinase positive (ALK+) anaplastic large-cell lymphoma (ALCL), and ALK-negative ALCL.

  • The incidence of various types of PTCL varies widely based on geography (Table 67–2).

TABLE 67–12016 WORLD HEALTH ORGANIZATION CLASSIFICATION OF MATURE T-CELL AND NATURAL KILLER–CELL NEOPLASMS (EXCLUDING PRIMARY CUTANEOUS LYMPHOMAS)
View Table||Download (.pdf)
TABLE 67–1 2016 WORLD HEALTH ORGANIZATION CLASSIFICATION OF MATURE T-CELL AND NATURAL KILLER–CELL NEOPLASMS (EXCLUDING PRIMARY CUTANEOUS LYMPHOMAS)
Peripheral T-cell lymphoma, NOS
Angioimmunoblastic T-cell lymphoma
Follicular T-cell lymphomaa
Anaplastic large-cell lymphoma, ALK-positive
Anaplastic large-cell lymphoma, ALK-negative
Breast implant–associated anaplastic large-cell lymphomaa
Enteropathy-associated T-cell lymphoma
Monomorphic epitheliotropic intestinal T-cell lymphoma
Adult T-cell leukemia/lymphoma
Hydroa vacciniforme–like lymphoma
T-cell prolymphocytic leukemia
T-cell large granular lymphocytic leukemia
Hepatosplenic T-cell lymphoma
Extranodal NK-/T-cell lymphoma, nasal type
Aggressive NK-cell leukemia
Systemic EBV+ T-cell lymphoproliferative disease of childhood (associated with chronic active EBV infection)
Chronic lymphoproliferative disorder of NK cellsa

ALK, anaplastic lymphoma kinase; EBV, Epstein-Barr virus; NK, natural killer; NOS, not otherwise specified.

aProvisional entity.

TABLE 67–2INCIDENCE OF LYMPHOMA SUBTYPES BY GEOGRAPHIC REGION
View Table||Download (.pdf)
TABLE 67–2 INCIDENCE OF LYMPHOMA SUBTYPES BY GEOGRAPHIC REGION
Subtype Registry PTCL-NOS AITL ALCL ALK+ ALCL ALK– NK/T ATL EATL
North America IPTCL 34% 16% 16% 8% 5% 2% 6%
BCCA 59% 5% 6% 9% 9% NAa 5%
COMPLETE 34% 15% 11% 8% 6% 2% 3%
Europe IPTCL 34% 29% 6% 9% 4% 1% 9%
Swedish 34% 14% 9% 15% 4% NAa 9%
Asia IPTCL 22% 18% 3% 3% 22% 25% 2%

AITL, angioimmunoblastic T-cell lymphoma; ALCL ALK–, anaplastic large-cell lymphoma anaplastic lymphoma kinase negative; ALCL ALK+, anaplastic large-cell lymphoma anaplastic lymphoma kinase positive; ATL, adult T-cell leukemia/lymphoma; BCCA, British Columbia Cancer Agency; COMPLETE, Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment; EATL, enteropathy-associated T-cell lymphoma; IPTCL, International Peripheral T-Cell Lymphoma Project; NA, not available; NK/T, natural killer–cell/T-cell lymphoma; NOS, not otherwise specified; PTCL, peripheral T-cell lymphoma.

aATL patients were excluded in both the BCCA and Swedish Registry Studies.

GENERAL ASPECTS OF PERIPHERAL T-CELL LYMPHOMAS

  • The diagnosis of PTCL is based on histologic features, immunophenotype, molecular studies, and clinical presentation.

  • B-cell lymphomas are characterized by immunophenotypic features, whereas T-cell lymphomas are characterized by antigen aberrancy, which may vary within a subtype and over the course of the disease.

  • Pathologists have a low concordance rate when reviewing the ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MH Privacy Center Close